Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking Ep 199

episode

Frankly Speaking About Family Medicine not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Frankly Speaking About Family Medicine

2026 ACC/AHA Dyslipidemia Guideline Review: Getting to the Heart of the Evidence - Frankly Speaking Ep 497 16 min · 10 Aug 2026

The Cannabis Conversation: Discussing the Risks with Adolescent Patients - Frankly Speaking Ep 496 13 min · 03 Aug 2026

Statins—Time to Stop the Worry! - Frankly Speaking Ep 495 11 min · 27 Jul 2026

Digital Dependence: Screening Adults for Screen Time - Frankly Speaking Ep 494 11 min · 20 Jul 2026

From Guidelines to Practice: Managing CKD in Primary Care - Frankly Speaking Ep 493 13 min · 13 Jul 2026

SPAN Small Changes to a Longer, Healthier Life - Frankly Speaking Ep 492 13 min · 06 Jul 2026

All episodes from Frankly Speaking About Family Medicine →

Report any issue

Source

Recorded23 Nov 2020

Publisherfeed.podbean.com ↗

Handlerec:9022715

Show notes

Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199 Overview: Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach. Guest: Alan Ehrlich, MD Music Credit: Richard Onorato

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in